[Immunomodulatory therapy improves quality of life with rheumatoid arthritis].

Pain, fatigue as well as functional and social impairments reduce the health-related quality of life in rheumatoid arthritis patients. Using numeric evaluations and qualitative questionnaires, it could be shown in both controlled drugs trials and in practice registries that modern drug therapy achieves an improvement in terms of quality of life (as well as in other patient-related treatment results). However, the improvements often do not achieve even the average quality-of-life levels seen in healthy people.